BioAsia 2025 in Hyderabad attracts global leaders, investments, and innovations in life sciences and pharma industry.

U.S.-based Parexel said it was piloting an AI model to generate drug safety reports 30-45 minutes faster than the manual ...

A total of 84 promising startups showcased groundbreaking innovations, offering solutions to some of the most pressing global ...

Apple shareholders on February 25 voted to keep the tech giant's diversity, equity and inclusion (DEI) policies, a win for ...

Eleven pharmaceutical companies have committed to investing Rs 5445 crore and creation of 9800 jobs in Telangana at Hyderabad ...

NEW DELHI – U.S. drugmaker Amgen plans to invest approximately $200 million this year in its new technology center located in ...

US biotech major Amgen will invest about $200 million this year in its new technology center in southern India.

Hyderabad: The 22nd edition of BioAsia 2025, Asia’s largest life sciences and healthcare conference, was inaugurated by Chief ...

US drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

Amgen opens new technology and innovation site in Hyderabad, to invest $200 million through 2025: Our Bureau, Bengaluru ...

EconoTimes is a global, independent publication that delivers comprehensive news, analysis, and insights on the economy, finance, and markets. Based in Korea, we offer a unique perspective on global ...